[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Monday, 26 June 2006, 12:22 GMT 13:22 UK
J&J buys up Pfizer unit for $16bn
Tablets
Over the counter medicines are in big demand
Johnson & Johnson (J&J) has agreed to buy drugs group Pfizer's consumer products business for $16.6bn (9.1bn).

The deal will cement J&J's position as the world's leading provider of over the counter (OTC) medicines.

Pfizer announced the sale of the unit, which includes brands such as Listerine mouthwash and Sudafed cold treatment, in February after a strategic review.

Following the deal, US-based Pfizer aims to buy back $7bn in ordinary stock in 2006, and another $10m next year.

According to reports, J&J's cash bid trumped other offers from UK companies GlaxoSmithKline and Reckitt Benckiser.

There has been a wave of merger and acquisition activity in the OTC sector recently amid growing demand for the products.

Governments are increasingly promoting self-medication in an effort to cut healthcare costs while companies are looking to the generic market as patents on prescription products run out.

In October, Reckitt Benckiser shelled out 1.93bn ($3.42bn) for Boots' Healthcare division - owner of the Nurofen, Strepsils and Clearasil brands.


SEE ALSO
Glaxo 'mulls bid for Pfizer unit'
02 Jun 06 |  Business
Pfizer wins Chinese Viagra ruling
05 Jun 06 |  Business
Reckitt Benckiser buys Boots unit
07 Oct 05 |  Business
Guidant takeover battle hots up
13 Jan 06 |  Business
Profit boost for French drugmaker
05 May 06 |  Business

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites



FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

PRODUCTS & SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific